Hangzhou Ledun Technology Co., Ltd. was established in November 2011 and is located on the 10th floor, Building 16, Phase 3, Eastern Medicine Port Town, Hangzhou, Zhejiang Province. It is a national high-tech enterprise specializing in custom chemical synthesis, pharmaceutical intermediates, innovative route process development and commercialization of active pharmaceutical ingredients (APIs), new drug development, sales, and technical services. Since its inception, the company has been honored with multiple titles, including National High-Tech Enterprise, National Sci-Tech SME, Zhejiang Provincial Sci-Tech SME, Hangzhou High-Tech Enterprise, Hangzhou "Qinglan" Enterprise, and Qiantang District "Swift" Enterprise. It currently holds nearly 10 patents.

The company employs over 40 staff members, including a R&D team of more than 30 people, with 8 holding doctoral degrees and 2 holding master's degrees. The team possesses strong technical capabilities, high innovation capacity, and extensive experience in technology transformation. Collaborating with experts from Tsinghua University, Zhejiang University, Lanzhou University, Nanjing University, China Jiliang University, and Zhejiang University of Technology, the company has developed core technology platforms such as microchannel reaction platforms, biocatalytic technology platforms, and chiral drug technology platforms through years of technical accumulation. The company continuously invests in hardware facilities and is equipped with advanced research equipment. It owns 1,600 square meters of office space in Hangzhou, including approximately 900 square meters of laboratories, featuring independent micro-reaction labs, biological labs, chemical synthesis labs, and analytical labs, enabling simultaneous research and development of over ten projects. The company has established strategic partnerships with five factories in Shandong, Zhejiang, Jiangsu, Fujian, and Jiangxi to meet the needs of special reaction types such as oxidation, nitration, sulfonation, low-temperature reactions, and high-temperature high-pressure reactions, laying a solid foundation for product industrialization.

The company adheres to the corporate philosophy of "Co-creation, Sharing, and Win-Win," with the goal of promoting the development of pharmaceutical and chemical technology and advancing China's pharmaceutical industry and new drug research to world-class standards. It is committed to providing high-quality products and services to domestic and international clients and sincerely hopes to collaborate with partners worldwide to achieve mutual success.